4 David Einhorn Coya Therapeutics Trades
David Einhorn acquired 1.27 Million Coya Therapeutics shares worth $10.7 Million. That's 0.51% of their equity portfolio (24th largest holding). The investor owns 15.44% of the outstanding Coya Therapeutics stock. The stake costed the investor $6.6 Million, netting the investor a gain of 62% so far.
Avg closing price
Price range
Increased shares by 172.2% (+806 Thousand shares)
Q4 2023
Avg closing price
$5.55
Price range
$3.30
-
$7.59
Increased shares by 19.2% (+75.4 Thousand shares)
Q3 2023
Avg closing price
$3.98
Price range
$3.32
-
$5.08
Increased shares by 0.1% (+203 shares)
Q1 2023
Avg closing price
$4.37
Price range
$3.85
-
$4.93
New holding (+392 Thousand shares)
Q4 2022
Avg closing price
$4.65
Price range
$4.57
-
$4.74
